Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol - Concepedia

Concepedia

Publication | Open Access

Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol

DOI Full Paper Access

240

Citations

23

References

2018

Year

Matthew R. Sydes, Melissa Spears, Malcolm D. Mason, Noel W. Clarke, David P. Dearnaley, Johann S. de Bono, Gerhardt Attard, S. Chowdhury, William Cross, Silke Gillessen,

Annals of Oncology

References

	Year	Citations

Page 1